Ulcerative colitis:: Analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?)

被引:0
|
作者
Özdil, S [1 ]
Akyüz, F [1 ]
Pinarbasi, B [1 ]
Demir, K [1 ]
Karaca, C [1 ]
Boztas, G [1 ]
Kaymakoglu, S [1 ]
Mungan, Z [1 ]
Besisik, F [1 ]
Cakaloglu, Y [1 ]
Ökten, A [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Gastroenterol, TR-34590 Istanbul, Turkey
关键词
ulcerative colitis; treatment; extraintestinal manifestations;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Evaluation of clinical, demographic and epidemiologic features of ulcerative colitis and therapy response of these patients. Methodology: Retrospectively, 116 patients (64.7% female) were enrolled in this study. Mean age and mean follow-up period were 36+/-16, 5+/-2 years, respectively. Results: The most common anatomic involvement was pancolitis (60.3%) and the others were as follows: left side 25%, rectum 13.8% and ileum (backwash ileitis) 0.9%. Extraintestinal manifestations were observed in 42.2% of patients (sacroiliitis 12%, primary sclerosing cholangitis 7.6%, pyoderma gangrenosum 2.4%, peripheral arthropathy 1.6%, autoimmune hepatitis 1.6%, steatosis 12.9%, gallstone 0.8%, perianal fistulas 0.8%, sagittal sinus thrombosis 0.8%, psoriasis 0.8%). Multiple extraintestinal manifestations were observed (primary sclerosing cholangitis + pyoderma gangrenosum) in 2 patients. Colonic perforation due to toxic megacolon was observed in only one patient during follow-up period. The mean period for remission was 3.7 months in 72% of patients with pancolitis by the treatment of 5-aminosalicylic acid (5-ASA) (2-3gr/day) + methylprednisolone (1mg/kg/day) +/- (for maintenance of remission) azathioprine (AZT) (1.5-2mg/kg/day); 3.7 months in 72% of left-sided colitis by 5-ASA +/- corticosteroid enemas +/- methylprednisolone (1mg/kg/day) +/- (for maintenance of remission) AZT (1.5-2mg/kg/day) and 3.7 months in 62.5% of patients with distal colitis by 5-ASA (PO +/- enema) +/- corticosteroid enemas. Colectomy was performed on 7 patients refractory to these treatments. Six patients (4 of them had pancolitis) were treated with cyclosporine (Cys) (4mg/kg/day, PO). Only one patient, a non-responder to Cys therapy, had colectomy. The mean remission time was 4.7 months in 80.6% of patients with extraintestinal involvement and 3.2 months in 71.2% of patients without extraintestinal involvement (P=0.002). Conclusions: Medical therapy was generally enough for the treatment. Cys and/or surgery can be another choice for the patients that do not respond to the medical therapy. Extraintestinal manifestations do not change the remission rate, but prolong the time to catch remission.
引用
收藏
页码:768 / 770
页数:3
相关论文
共 43 条
  • [21] Extensive ulcerative colitis and extraintestinal manifestations in a patient with HIV infection and significant CD4 T-cell lymphopenia
    Louis, E
    Moutschen, MP
    De Marneffe, P
    Malherbe, R
    Closon, T
    Jean, MT
    Demonty, J
    Belaiche, J
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1997, 21 (11): : 884 - 887
  • [23] Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis
    Sang, Li-Xuan
    Chang, Bing
    Zhang, Wen-Liang
    Wu, Xiao-Mei
    Li, Xiao-Hang
    Jiang, Min
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (15) : 1908 - 1915
  • [24] Do immunosuppressants really work as maintenance therapy after the achievement of remission of severe ulcerative colitis?
    Makoto Naganuma
    Toshifumi Hibi
    Journal of Gastroenterology, 2002, 37 : 315 - 317
  • [25] Effect of probiotic for maintenance of remission in adult ulcerative colitis: a meta-analysis
    Peng, Xiulan
    Zhang, Jixiang
    Ji, Mengyao
    Jiasong
    Dong, Weiguo
    Liu, Weibing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 20866 - 20874
  • [26] Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis
    Lindgren, S
    Löfberg, R
    Bergholm, L
    Hellblom, M
    Carling, L
    Ung, KA
    Schiöler, R
    Unge, P
    Wallin, C
    Ström, M
    Persson, T
    Suhr, OB
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (06) : 705 - 710
  • [27] Extra Intestinal Manifestations of 100 cases of Ulcerative Colitis and its correlation with extent and behavior of disease
    Sulehria, Sohail Bashir
    Aslam, M. Naeem
    Athar, Ch Adnan Ahmad
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (01): : 296 - 298
  • [28] Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission
    Kim, Jae Hyun
    Cheon, Jae Hee
    Park, Yehyun
    Lee, Hyun Jung
    Park, Soo Jung
    Kim, Tae Il
    Kim, Won Ho
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (09) : 1069 - 1074
  • [29] Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission
    Hamer, Henrike M.
    Jonkers, Daisy M. A. E.
    Vanhoutvin, Steven A. L. W.
    Troost, Freddy J.
    Rijkers, Ger
    de Bruine, Adriaan
    Bast, Aalt
    Venema, Koen
    Brummer, Robert-Jan M.
    CLINICAL NUTRITION, 2010, 29 (06) : 738 - 744
  • [30] Mesalazine in left-sided ulcerative colitis: Efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing
    Bokemeyer, Bernd
    Hommes, Daan
    Gill, Ivo
    Broberg, Per
    Dignass, Axel
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (04) : 476 - 482